Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Hussain

Showing results (51-60 of 213) with videos related to

Pageof 22
Sort By:
Cancer Research|May 3, 2006
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancerYiwei Li, Omer Kucuk, Maha Hussain, et al.
Cancer|March 22, 2017
The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignanciesKalen J Rimar, Phuoc T Tran, Richard S Matulewicz, et al.
The Journal of Urology|July 22, 2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available TherapiesE David Crawford, Celestia S Higano, Neal D Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancerDavid J Vaughn, Catherine M Broome, Maha Hussain, et al.
BMC Cancer|January 20, 2005
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cellsYiwei Li, Maha Hussain, Sarah H Sarkar, et al.
Molecular Cancer Therapeutics|March 16, 2005
Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cellsYiwei Li, Xin Hong, Maha Hussain, et al.
Investigational New Drugs|October 31, 2003
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancerMaha Hussain, Ulka Vaishampayan, Lance K Heilbrun, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Urology Case Reports|April 19, 2021
Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomyArjun Sarkar, Mohammad Rashid Siddiqui, Richard J Fantus, et al.
Oncology Nursing Forum|May 16, 2002
Couples' experiences with prostate cancer: focus group researchJanet Harden, Ann Schafenacker, Laurel Northouse, et al.
Pageof 22

Showing results (51-60 of 213) with videos related to

Sort By:
Pageof 22
Cancer Research|May 3, 2006
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancerYiwei Li, Omer Kucuk, Maha Hussain, et al.
Cancer|March 22, 2017
The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignanciesKalen J Rimar, Phuoc T Tran, Richard S Matulewicz, et al.
The Journal of Urology|July 22, 2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available TherapiesE David Crawford, Celestia S Higano, Neal D Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancerDavid J Vaughn, Catherine M Broome, Maha Hussain, et al.
BMC Cancer|January 20, 2005
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cellsYiwei Li, Maha Hussain, Sarah H Sarkar, et al.
Molecular Cancer Therapeutics|March 16, 2005
Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cellsYiwei Li, Xin Hong, Maha Hussain, et al.
Investigational New Drugs|October 31, 2003
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancerMaha Hussain, Ulka Vaishampayan, Lance K Heilbrun, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Urology Case Reports|April 19, 2021
Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomyArjun Sarkar, Mohammad Rashid Siddiqui, Richard J Fantus, et al.
Oncology Nursing Forum|May 16, 2002
Couples' experiences with prostate cancer: focus group researchJanet Harden, Ann Schafenacker, Laurel Northouse, et al.
Pageof 22